Gail Tomlinson, M.D., Ph.D.
Professor of pediatrics, division chief of hematology-oncology and the Greehey Distinguished Chair in the Genetics of Cancer
Division of Hematology-Oncology
Phone: 210-704-3405
Education:
M.D., George Washington University Medical School, 1984
Ph.D., biochemistry, Duke University, 1982
B.S., biology, Dickinson College, Carlisle, Penn., 1974
Training:
Fellowship, pediatric hematology-oncology, UT Southwestern Medical Center, Dallas, 1989-92
Fellowship, Department of Pediatrics, M.D. Anderson Cancer Center, Houston, 1988-89
Residency, pediatrics, Children's Hospital National Medical Center, Washington DC, 1984-87
Board Certification:
Pediatrics, 1988; hematology-oncology, 1992
Recent Publications:
Litten JB and Tomlinson GE. 2007. Is preoperative chemotherapy useful for nonmetastatic Wilms’ tumor? Nature Clinical Practice 4:272-3
Patterson A, Leitch AM, Weatherall P, Zhou XP, Eng E, Tomlinson GE. 2006. Multiple findings leading to a diagnosis of a cancer predisposition syndrome: Severe fibrocystic breast disease in a 16-year old female with PTEN hamartoma tumor syndrome (PHTS), J. Clin. Onc., 24:525-527.
Tomlinson GE, Breslow N, Dome J, Guthrie K, Norkool P, Li S, Beckwith JB. Thomas, P, D'Angio G, Green D. 2005. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study Group: Age as a prognostic factor, J. Clin. Onc. 23: 7641-5.
Research interests:
Genetic predisposition to cancer, Hepatoblastoma, Hereditary breast cancer, Other Pediatric Tumors, Population-specific aspects of childhood cancer, von Hippel-Lindau disease
Anne-Marie R. Langevin, M.D.
Associate professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-3405
Education:
M.D., University of Montreal; Montreal, Canada, 1980
Postgraduate Training:
Fellowship, Drug Development, University of North Carolina, 1988-89
Fellowship, Pediatrics-Hematology/Oncology, Hospital for Sick Children; Toronto, Canada, 1985-88
Resident, Hematology Med./Path., Hospital Maisonneuve Rosemont; Montreal, Canada, 1983-84
Resident, Hematology, Hospital Ste-Justine; Montreal, Canada, 1983
Resident, Hematology, Hotel-Dieu de Montreal; Montreal, Canada, 1982-83
1980-82 - Jr. Resident, Internal Medicine, Hospital Maisonneuve Rosemont; Montreal, Canada
Board Certification:
Pediatrics, 1997; Hematology/Oncology, 1998
Publications:
Baillargeon J, Lewis M, Estrada J, Grady JJ, Mullins J, Pitney A, Pollock BH, Langevin AM. Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia. Pediatr Blood Cancer 2006 Oct
Baillargeon J, Lewis M, Estrada J, Mullins J, Pitney A, Ma JZ, Chisholm GB, Pollock BH, Langevin AM. Obesity and survival in a cohort of predominantly Hispanic children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2006 Sep;28(9):575-578.
Boomgaars LR, Megason GC, Pullen J, Langevin AM, Weitman SD, Hershon L, Kuhn JG, Bernstein M, Blainey SM. Phase I trial of irofulven (MGI 114) in pediatric patients with solid tumors. Pediatr Blood Cancer 2006 Aug;47(2):163-168.
Interests: Drug Development in Pediatric Oncology, Development of Cancer Control Studies in Pediatric Oncology, bone and soft tissue sarcomas, solid tumors in children, adolescents and young adults.
Reginald H. Moore, M.D.
Associate professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-3454
Education:
M.D., Uniformed Services University of the Health Sciences, 1982
B.S., biology, The College of William and Mary, 1976
Postgraduate Training:
Fellowship, Pediatric Hematology/Oncology, Uniformed Services University of the Health Services, 1988-91
Residency, Pediatrics, Brooke Army Medical Center, 1982-85
Internship, Pediatrics, Brooke Army Medical Center, 1982-83
Board Certification:
Pediatrics, 1987
Publications:
Chan J., Moore R.: Sickle Cell Anemia. In: DiPiro JT, Talbert RL (eds). Pharmco Therapy: A Pathophysiological Approach, 6th Edition, McGraw Hill, 2005.
Bsoul SA, Terezhalmy GT, Riley CK, Moore RH. Developmental submandibular salivary gland depression. Quintessence Int 2002 Mar;33(3):242-243.
Interests:
Pediatric Forensic Child Abuse, Sickle Cell Disease, Leukemia & Lymphoma
Paul J. Thomas, M.D.
Associate professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-2844
Education:
M.D., George Washington University, Washington, DC, 1970
B.S., general physical sciences: chemistry, University of Maryland, 1966
Postgraduate Training:
Fellowship, Pediatric Hematology/Oncology, Walter Reed Army Medical Center, Washington, D.C., 1977-79
Residency, Pediatrics, Walter Reed Army Medical Center, Washington, D.C., 1971-73
Internship, Pediatrics, Walter Reed General Hospital, Washington, D.C., 1970-71
Board Certification:
Pediatrics, 1975; Hematology/Oncology, 1980
Publications:
Swinney RM, Wall DA, Thomas PJ, Grimley MS, Taylor C, Tomlinson GE. Familial childhood leukemia cluster with multiple aggressive early-onset hematological malignancies. Leuk Lymphoma 2006 May;47(5):930-932.
Baillargeon J, Langevin AM, Lewis M, Thomas PJ, Mullins J, Dugan J, Pollock BH. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia. Cancer 2005 Dec;104(12):2858-2861.
Baillargeon JG, Langevin AM, Lewis M, Thomas PJ, Mullins J, Estrada J, Pitney A, Sacks N, Pollock BH,. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia Cancer 2005 Apr;103(8):1725-1729.
Interests:
Treatment of childhood cancer in the Children's Oncology Group
Melissa Frei-Jones, M.D.
Assistant professor of pediatrics
Division of Hematology-Oncology
Education:
M.S., clinical investigation, Washington University, St. Louis
M.D., UT Southwestern Medical School, Dallas
B.S., B.A., Southern Methodist University, Dallas
Training:
Fellowship, pediatric hematology-oncology, St. Louis Children’s Hospital
Residency, Children’s Medical Center, Dallas
Certification:
American Board of Pediatrics
Shannon Carpenter, M.D.
Clinical assistant professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-2061
Education:
M.S., Clinical Investigation, UT Health Science Center, San Antonio, 2006
M.D., Virginia Commonwealth University, Richmond, VA, 1998
B.A., biochemistry, University of Virginia, Charlottesville, VA, 1993
Training:
Fellowship, Pediatric Hematology/Oncology, Duke University, 2001-04
Residency, pediatrics, Children's Hospital Medical Center, 1998-01
Board Certification:
Pediatrics, 2001; Hematology/Oncology, 2004
Recent Publications:
Carpenter SL, Zimmerman, SA, Ware, RE. Acute parvovirus B19 infection mimicking congenital dyserythropoietic anemia J Pediatr Hematol Oncol 2004 Feb;(2):133-135.
Interests:
Pediatric hemophilia, thrombophilia, sickle cell disease, and general hematologic disorders
Shafqat Shah, Ph.D.
Clinical associate professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-3185
Education:
M.D., Duke University School of Medicine, Durham, NC, 1991
B.A., molecular biology, Johns Hopkins University, 1987
Postgraduate Training:
Fellowship, Pediatric Hem/Onc, University of Texas Health Science Center, San Antonio, 1994-97
Residency, Pediatrics, Emory University, Atlanta, 1991-94
Board Certification:
Pediatrics, 1994; Hematology/Oncology, 1998
Publications:
Shah S, Baillargeon JG, Pollock BH, Whitenton K. Assessment of Body Image in Childhood Cancer Surivors in South Texas 2006 May. (Abstract #609, American Society of Pediatric Hemtaology/Oncology 2006 Abstracts)
Shah S, Vega R, Hereditary Spherocytosis, Pediatrics in Review, March 2004
K Krishnan, S Shah, H Sabio, V McKie. Mycoplasma Encephalitis Complicates the Course of Acute Chest Syndrome in an Eight-Year old with Sickle Cell Anemia 2001 Mar. p. A32. (Journal of Pediatric Hematology/Oncology; vol. 23, no. 3).
Interests:
Childhood Cancer Survivorship
Jaclyn Y. Hung, Ph.D.
Associate professor of pediatrics
Division of Hematology-Oncology
210-562-9025
Education:
Ph.D., physics, University of Brittish Columbia, 1992
M.S., physics, University of Brittish Columbia, 1988
B.S., physicis & mathematics, University of Prince Edward Island, 1985
Training:
Post-doctoral fellowship, cancer biology & genetics, UT Southwestern Medical Center, Dallas, 1992-95
Recent Publications:
Ho, M.M., Ng, A.V., Lam, S., Hung J. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. (Selected by editor as a highlighted article) Cancer Research 2007;67(10):4827-4833.
Interests:
Cancer stem like cells, microRNAs, drug resistance, cancer biology and genetics
Leanne Embry Segovia, Ph.D.
Assistant professor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-2987
Education:
Ph.D., Clinical Psychology, University of Southern Mississippi, 2003
M.A., Clinical Psychology, University of Southern Mississippi, 1996
B.A., Psychology, Emory University, 1992
Postgraduate Training:
2003-04, Postdoctoral Fellowship, Clinical Psychology, UT Health Science Center, San Antonio
Research interests:
Cognitive and psychological sequelae of pediatric cancer diagnoses and treatment; impact of cancer on the lives of adolescents and young adults; fatigue and physical activity in pediatric cancer
Clinical interests:
Coping with diagnosis and treatment of childhood cancer and blood disorders
Beneza Marquez, Psy.D.
Instructor of pediatrics
Division of Hematology-Oncology
Phone: 210-704-2853
Education:
Psy.D., counseling psychology, Our Lady of the Lake University, 2005
M.S., marraige and family therapy, Our Lady of the Lake University, 1999
B.A., psychology, Our Lady of the Lake University, 1997
Training:
Internship, South Texas Veterans Health Care System, 2004-05
Certification:
Texas State Board of Examiners of Professional Counselors, 2003
Recent Publications:
Marquez B. Understanding Multiple Relationships: Perspectives from Mexican Clinets and Therapists 2005.
Interests:
Biofeedback, Hypnosis, Provide Mental Health Services to Spanish speaking population
Christina Aguilar, M.D., M.P.H
Faculty associate
Division of Hematology-Oncology
562-9123
Education:
M.S., biology, Universidad de Monterrey, Mexico, 1974
M.D., medicine, Universidad Autonoma de Nuevo Leon, 1980
M.P.H., UT Health Science Center, San Antonio, 1989
Publications:
Ravandi F, Jilani I, Estey E, Kantarjian H, Dey A, Aguilar C, Jitkaroon C, Giles F, O'brien S, Keating M, Albitar M. Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML). Leuk Res 2006 Dec
Albitar M, Potts SJ, Giles FJ, O'Brien S, Keating M, Thomas D, Clarke C, Jilani I, Aguilar C, Estey E, Kantarjian H. Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer 2006 Apr;106(7):1587-1594.
Faderl S, Do KA, Johnson MM, Keating M, O‘brien S, Jilani I, Ferrajoli A, Ravandi-Kashani F, Aguilar C, Dey A, Thomas DA, Giles FJ, Kantarjian HM, Albitar M. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Blood 2005 Dec;106(13):4303-4307.
Patricia Amerson, RN, CPNP
Clinical faculty associate
Division of Hematology-Oncology
210-704-3862
Education:
B.S.N, nursing, UT Health Science Center, San Antonio, 1998
M.S.N., pediatric nurse practitioner, UT Health Science Center, San Antonio, 2001
Training:
Board of Nurse Examiners, 1989
|